Clear Impact logo

Communicable Disease Surveillance

Measures

Time
Period
Current Actual Value
Current Target Value
Current
Trend
Baseline
% Change
Disease
Influenza monthly activity
I
Dec 2023
150
440
2
-70%
Disease
Chlamydia
I
Dec 2023
38
45
1
-28%
Disease
Gonorrhea
I
Dec 2023
7
24
1
-70%
Disease
Hepatitis C - Chronic
I
Dec 2023
9
12
1
-31%
Disease
Influenza associated hospitalization
I
Dec 2023
12
18
2
-14%
Disease
Hepatitis A
I
Dec 2023
4
5
1
-43%
Disease
Lyme Disease
I
Dec 2023
2
5
2
100%
Disease
Campylobacteriosis
I
Dec 2023
8
7
1
167%
Disease
Pertussis (Whooping Cough)
I
Dec 2023
1
2
1
-50%
Disease
Hepatitis B
I
Dec 2023
3
4
1
0%
Disease
Salmonellosis
I
Dec 2023
2
2
1
100%
Disease
Legionnaires' disease
I
Dec 2023
3
1
1
200%
Disease
Cryptosporidiosis
I
Dec 2023
0
0
3
0%
Disease
HIV/AIDS - New cases reported
I
2021
3
4
3
-70%
Disease
Number of persons living with a diagnosis of HIV per 100,000 population
I
2019
110.8
8
39%

Clear Impact Suite is an easy-to-use, web-based software platform that helps your staff collaborate with external stakeholders and community partners by utilizing the combination of data collection, performance reporting, and program planning.

Scorecard Container Measure Action Actual Value Target Value Tag S A m/d/yy m/d/yyyy